These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3445731)

  • 1. [Characteristics of the immune response of children in the Arctic to live measles vaccine].
    Anpilogova LV; Dubov AV; Popov VF; Iunasova TN; Leĭko AP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):51-3. PubMed ID: 3445731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The characteristics of the synthesis of specific antihemagglutinins and antihemolysins in subjects inoculated with live measles vaccine in different climatic and geographical areas].
    Novitskiĭ IA; Tikhonova NT; Mamaeva TA; Dubov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):64-8. PubMed ID: 7941872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measles morbidity among children inoculated against this infection].
    Bolotovskiĭ VM; Gelikman BG; Mikheev IV; Titova NS; Kikosh GV
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):38-43. PubMed ID: 3705811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 6. Malnutrition and seroconversion following measles immunization.
    Ekunwe EO
    J Trop Pediatr; 1985 Dec; 31(6):290-1. PubMed ID: 3937902
    [No Abstract]   [Full Text] [Related]  

  • 7. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 8. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic evaluation of measles vaccine in preschool and school children].
    Soto C; Cordero J; Vergara MI
    Rev Chil Pediatr; 1981; 52(6):491-5. PubMed ID: 7347862
    [No Abstract]   [Full Text] [Related]  

  • 10. [Postvaccinal immunity study of children inoculated with a live measles vaccine].
    Bol'shakova SL
    Tr Inst Im Pastera; 1979; 53():75-8. PubMed ID: 162466
    [No Abstract]   [Full Text] [Related]  

  • 11. [The assessment of the immunogenicity of different batches of live L-16 measles vaccine in urban and rural localities].
    Ninashvili NZ; Gelikman BG; Shavdiia NT; Elikashvili MIu; Gogokhia TsN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):72-4. PubMed ID: 8079578
    [No Abstract]   [Full Text] [Related]  

  • 12. [The immune response of children with an iron deficiency to vaccination with a live measles vaccine].
    Kazakova LM; Makrushin IM; Tsvetova GV; Arsent'eva TN; Shabaldin AV
    Pediatriia; 1992; (7-9):36-7. PubMed ID: 1475138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-laboratory and seroepidemiological examinations of children immunized with live measles vaccine prepared from genetically homogeneous strain Moscow-5].
    Unanov SS; Iuminova NV; Pasechnik AL; Sokolova AF; Gordienko NM
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Sep; (9):49-54. PubMed ID: 4072497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immune response to aerosolized measles vaccine.
    Amler RW; Orenstein WA; Bart KJ
    JAMA; 1984 May; 251(18):2408. PubMed ID: 6708291
    [No Abstract]   [Full Text] [Related]  

  • 15. The status of measles after five years of mass vaccination in the USSR.
    Burgasov PN; Andzaparidze OG; Popov VF
    Bull World Health Organ; 1973; 49(6):571-6. PubMed ID: 4548384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles vaccine failure after documented seroconversion.
    Reyes MA; de Borrero MF; Roa J; Bergonzoli G; Saravia NG
    Pediatr Infect Dis J; 1987 Sep; 6(9):848-51. PubMed ID: 3670952
    [No Abstract]   [Full Text] [Related]  

  • 17. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a measles vaccine manufactured in India.
    Shaikh N; Raut SK; Bedekar SS; Phadke MA; Banerjee K
    Indian Pediatr; 1992 Jul; 29(7):883-7. PubMed ID: 1428138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-measles humoral immunity in children with thymus hyperplasia].
    Gurvich EB; Lysenkova NV; Shishatskaia SN; Vaganov PD; Ozeretskovskiĭ NA
    Pediatriia; 1989; (9):31-3. PubMed ID: 2587164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.